Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

GTC Biotherapeutics awaits EMEA comments regarding ATryn MAA

March 22, 2005

Drug-drug interactions with clopidogrel and St. John's wort

March 18, 2005

PAR-1 antagonist exerts antithrombotic effects in a primate model

March 15, 2005

Two series of novel serine protease inhibitors described by Genentech scientists

March 11, 2005

Clinical evaluation of prasugrel as inhibitor of platelet aggregation

March 10, 2005

Yamanouchi synthesizes potent and orally active Factor Xa inhibitors

March 8, 2005

Coagulation factor VIIa inhibitors developed by Bristol-Myers Squibb

March 1, 2005

Novel class of Factor XIIIa inhibitors synthesized by Apotex

March 1, 2005

Therapeutic benefits of rFVIIa in patients with acute intracerebral hemorrhage

Feb. 28, 2005

Novel factor Xa (FXa) inhibitors discovered at Merck KGaA

Feb. 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...